Drug Shortage Report for APO-CABERGOLINE

Last updated on 2021-03-02 History
Report ID 41136
Drug Identification Number 02455897
Brand name APO-CABERGOLINE
Common or Proper name CABERGOLINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) CABERGOLINE
Strength(s) 0.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 8 BTL
ATC code G02CB
ATC description OTHER GYNECOLOGICALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-26
Estimated end date Unknown
Actual end date 2021-03-01
Shortage status Resolved
Updated date 2021-03-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2021-03-02 English Compare
v24 2021-03-01 French Compare
v23 2021-03-01 English Compare
v22 2020-03-30 French Compare
v21 2020-03-30 English Compare
v20 2020-02-18 French Compare
v19 2020-02-18 English Compare
v18 2019-10-07 French Compare
v17 2019-10-07 English Compare
v16 2019-09-09 French Compare
v15 2019-09-09 English Compare
v14 2019-07-12 French Compare
v13 2019-07-12 English Compare
v12 2019-04-29 French Compare
v11 2019-04-29 English Compare
v10 2019-04-22 French Compare
v9 2019-04-22 English Compare
v8 2019-03-15 French Compare
v7 2019-03-15 English Compare
v6 2018-11-30 French Compare

Showing 1 to 20 of 25